Compass Therapeutics, Inc.CMPXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank86
Studio
Year-over-Year Change

Free cash flow yield

Latest
-5.81%
↑ 71% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-20.37%
Historical baseline
PeriodValueYoY Change
2025-5.81%+74.3%
2024-22.58%-10.1%
2023-20.51%-216.1%
2022-6.49%+39.1%
2021-10.65%-89.2%
2020-5.63%+22.5%
2019-7.27%+91.3%
2018-84.00%-